Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FWSEB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,592.80 for Dupixent 300 mg/2 ml syringes on July 7, 2025, with completion scheduled for July 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making it a specialty pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp supplies a broad range of medications and medical commodities to support the Defense Health Agency and other federal healthcare programs worldwide. The company's position as a prime vendor under this expansive IDC demonstrates its capability to fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWSEB?
SPE2DB25FWSEB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 7, 2025.
How much is contract SPE2DB25FWSEB worth?
The government has obligated $14,593 on SPE2DB25FWSEB.
Is contract SPE2DB25FWSEB an order under another contract?
Yes. SPE2DB25FWSEB is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSEB competed?
The extent of competition for SPE2DB25FWSEB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award